Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.82 SEK | -0.90% | -4.96% | +5.63% |
04-25 | Polygiene Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-15 | Polygiene Group AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 182.6 | 785.8 | 1,772 | 298.4 | 305 | 322.2 | - | - |
Enterprise Value (EV) 1 | 178.9 | 782.9 | 1,722 | 251.9 | 264.7 | 276.2 | 265.2 | 249.2 |
P/E ratio | -35.6 x | -479 x | 27.4 x | 14.1 x | -1 x | 16 x | 19.6 x | 18.4 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 2.65 x | 9.36 x | 9.76 x | 1.72 x | 2.69 x | 2.22 x | 2 x | 1.83 x |
EV / Revenue | 2.6 x | 9.33 x | 9.48 x | 1.45 x | 2.33 x | 1.9 x | 1.65 x | 1.42 x |
EV / EBITDA | -33.3 x | 1,117 x | 37.2 x | 12.4 x | -21.7 x | 12.6 x | 11.5 x | 9.58 x |
EV / FCF | 30.5 x | -696 x | 50.4 x | -4.97 x | 444 x | 30.7 x | 20.4 x | 17.8 x |
FCF Yield | 3.28% | -0.14% | 1.98% | -20.1% | 0.23% | 3.26% | 4.9% | 5.62% |
Price to Book | 5.3 x | 28.6 x | 3.41 x | 0.5 x | 1.05 x | 1.01 x | 0.97 x | 0.92 x |
Nbr of stocks (in thousands) | 20,516 | 20,516 | 35,550 | 36,527 | 36,527 | 36,527 | - | - |
Reference price 2 | 8.900 | 38.30 | 49.85 | 8.170 | 8.350 | 8.820 | 8.820 | 8.820 |
Announcement Date | 20-02-27 | 21-02-25 | 22-02-24 | 23-02-16 | 24-02-15 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 68.8 | 83.93 | 181.6 | 173.6 | 113.5 | 145 | 161 | 176 |
EBITDA 1 | -5.379 | 0.701 | 46.29 | 20.34 | -12.2 | 22 | 23 | 26 |
EBIT 1 | -6.571 | -1.051 | 43.16 | 15.99 | -312.6 | 15 | 18 | 21 |
Operating Margin | -9.55% | -1.25% | 23.76% | 9.21% | -275.31% | 10.34% | 11.18% | 11.93% |
Earnings before Tax (EBT) 1 | -6.623 | -1.086 | 40.47 | 15.96 | -313.1 | 14 | 17 | 21 |
Net income 1 | -5.171 | -1.736 | 64.18 | 21.84 | -303.6 | 20 | 17 | 18 |
Net margin | -7.52% | -2.07% | 35.34% | 12.58% | -267.42% | 13.79% | 10.56% | 10.23% |
EPS 2 | -0.2500 | -0.0800 | 1.820 | 0.5800 | -8.310 | 0.5500 | 0.4500 | 0.4800 |
Free Cash Flow 1 | 5.866 | -1.125 | 34.15 | -50.64 | 0.596 | 9 | 13 | 14 |
FCF margin | 8.53% | -1.34% | 18.81% | -29.18% | 0.52% | 6.21% | 8.07% | 7.95% |
FCF Conversion (EBITDA) | - | - | 73.78% | - | - | 40.91% | 56.52% | 53.85% |
FCF Conversion (Net income) | - | - | 53.21% | - | - | 45% | 76.47% | 77.78% |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 20-02-27 | 21-02-25 | 22-02-24 | 23-02-16 | 24-02-15 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 |
---|---|---|---|---|---|
Net sales 1 | 40.18 | 45.11 | 47.47 | 40.98 | 40 |
EBITDA | 6.991 | 9.323 | 9.619 | 5.118 | - |
EBIT | 6.153 | 3.796 | 11.54 | 7.049 | - |
Operating Margin | 15.31% | 8.41% | 24.32% | 17.2% | - |
Earnings before Tax (EBT) 1 | 4.123 | 3.783 | 11.53 | 7.046 | -6.384 |
Net income 1 | 39.03 | 7.121 | 17.18 | 5.724 | -5.131 |
Net margin | 97.15% | 15.79% | 36.19% | 13.97% | -12.83% |
EPS | 1.100 | - | - | - | - |
Dividend per Share | - | - | - | - | - |
Announcement Date | 22-02-24 | 22-04-28 | 22-07-28 | 22-10-27 | 23-02-16 |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - | - | - |
Net Cash position 1 | 3.74 | 2.81 | 50.2 | 46.6 | 40.3 | 46 | 57 | 73 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | 5.87 | -1.13 | 34.2 | -50.6 | 0.6 | 9 | 13 | 14 |
ROE (net income / shareholders' equity) | -13.6% | -6.12% | 11% | 3.93% | -68.7% | 6.6% | 5.1% | 5.2% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share 2 | 1.680 | 1.340 | 14.60 | 16.20 | 7.970 | 8.720 | 9.080 | 9.590 |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | 1.98 | 4.04 | 3.45 | 49.1 | 3.19 | 5 | 5 | 5 |
Capex / Sales | 2.88% | 4.82% | 1.9% | 28.3% | 2.81% | 3.45% | 3.11% | 2.84% |
Announcement Date | 20-02-27 | 21-02-25 | 22-02-24 | 23-02-16 | 24-02-15 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.63% | 29.55M | |
+17.76% | 66.6B | |
+0.84% | 48.75B | |
+17.11% | 41.45B | |
+22.26% | 26.74B | |
+11.45% | 19.55B | |
+3.89% | 18.21B | |
-21.31% | 16.02B | |
+3.82% | 15.62B | |
-7.57% | 15.33B |
- Stock Market
- Equities
- POLYG Stock
- Financials Polygiene Group AB